SCHEMBL6887545

SCHEMBL6887545

COCCn1c(C2CC2)nc2ccc(N3CCN4CCC3CC4)cc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.46
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CHRNA7 P36544 2/20 0.41
TSHR P16473 5/20 0.40
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
RAB9A P51151 5/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 3/20 0.40
ATM Q13315 1/20 0.40
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
HPGD P15428 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
HTT P42858 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HRH1 P35367 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6887916 0.88 CHRNA7 (0.43) BRD4MEN1KMT2ACHRNA7TSHR
SCHEMBL6886386 0.87 CHRNA7 (0.43) MEN1KMT2ACHRNA7TSHRNPC1
SCHEMBL6889276 0.85 CHRNA7 (0.42) MEN1KMT2ACHRNA7TSHRNPC1
SCHEMBL6887453 0.84 CHRNA7 (0.44) MEN1KMT2ACHRNA7TSHRNPC1
SCHEMBL6888328 0.84 PARG (0.47) CHRNA7
SCHEMBL6886315 0.83 HPGD (0.42) KMT2ACHRNA7SMN1; SMN2KDM4ELMNA
SCHEMBL6889157 0.82 ALDH1A1 (0.42) CHRNA7TSHRKDM4EHSD17B10POLB
SCHEMBL6889887 0.82 CHRNA7 (0.40) MEN1KMT2ACHRNA7TSHRKDM4E
SCHEMBL6886701 0.82 CHRNA7 (0.41) MEN1KMT2ACHRNA7TSHRNPC1
SCHEMBL6886562 0.81 ALDH1A1 (0.45) TSHRHSD17B10POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488520-B1 CONDENSED AZINE-DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME (NL) 2015-09-02 EP disclosed
EP-2488520-B1 CONDENSED AZINE-DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME (NL) 2015-09-02 EP disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
WO-2011045258-A1 CONDENSED AZINE - DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR N.V. ORGANON (NL) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208796-A1 HETEROCYCLIC DERIVATIVES CHRNA5, CHRM5, CHRNA7 BRD4 499/4885MEN1 3191/4885KMT2A 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.